BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3910659)

  • 1. Moyamoya in sickle cell disease demonstrated by DSA and Hexabrix.
    Ramsewak W; Gill G; Lo R
    J Can Assoc Radiol; 1985 Dec; 36(4):332-3. PubMed ID: 3910659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moya moya disease: use of digital subtraction angiography in its diagnosis.
    Hasuo K; Tamura S; Kudo S; Uchino A; Carlos R; Matsushima T; Kurokawa T; Kitamura K; Matsuura K
    Radiology; 1985 Oct; 157(1):107-11. PubMed ID: 3898215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal iodine concentration in digital subtraction arteriography.
    Norman D; Brant-Zawadzki M; Gould RG; Newton TH
    Invest Radiol; 1984; 19(6 Suppl):S368-70. PubMed ID: 6392167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind clinical comparison of Hexabrix and Renografin-76 for intravenous digital subtraction angiography.
    Turski PA; Gentry LR; Matozzi F; Verma S
    Invest Radiol; 1984; 19(6 Suppl):S363-5. PubMed ID: 6392165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic side effects of meglumine ioglicate, meglumine sodium ioxaglate and iohexol in aortofemoral angiography: comparison of a high-osmolar and two low-osmolar radiological contrast media.
    Wiebe V; Straub H
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():78-84. PubMed ID: 6139084
    [No Abstract]   [Full Text] [Related]  

  • 6. Contrast media tonicity. Part II. Isotonic ioxaglate vs. standard renografin for IV-DSA evaluation of the carotid bifurcation, a double-blind prospective clinical trial.
    Burbank FH; Bradley BR; Yegnashankaran S; Enzmann DR
    Invest Radiol; 1986 Apr; 21(4):340-7. PubMed ID: 3516921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of hexabrix and Renografin 60 in peripheral arteriography.
    Sacks BA; Ellison HP; Bartek S; Vine HS; Palestrant AM
    AJR Am J Roentgenol; 1983 May; 140(5):975-7. PubMed ID: 6601445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebral angiography with a new low osmolarity contrast medium (Hexabrix). Analysis of 3500 cerebral angiograms with 7 contrast media].
    Bartko D; Brezná M; Koník I; Dornetzhuberová M
    Cesk Neurol Neurochir; 1982 Jan; 45(1):41-8. PubMed ID: 7060172
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative trial of sodium meglumine ioxaglate (Hexabrix) and iopamidol (Niopam) for cerebral angiography.
    Molyneux AJ; Sheldon PW; Yates DA
    Br J Radiol; 1982 Dec; 55(660):881-4. PubMed ID: 6756533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind clinical study comparing tolerability, safety, and efficacy of Hexabrix and Renografin-76 for intravenous subtraction angiography.
    Nelson JA; Sherry RA
    Invest Radiol; 1984; 19(6 Suppl):S366-7. PubMed ID: 6392166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omnipaque vs. Hexabrix in intravenous DSA of the carotid arteries: randomized double-blind crossover study.
    Nakstad PH; Bakke SJ; Kjartansson O; von Krogh J
    AJNR Am J Neuroradiol; 1986; 7(2):303-4. PubMed ID: 3082163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radionuclide cerebral angiography in moyamoya disease.
    Maeda T; Mori H; Hisada K; Sugino M
    Clin Nucl Med; 1979 Dec; 4(12):513-5. PubMed ID: 527289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital subtraction angiography in pediatric cerebrovascular occlusive disease.
    Faerber EN; Griska LA; Swartz JD; Capitanio MA; Popky GL
    Radiology; 1984 Aug; 152(2):391-4. PubMed ID: 6377384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-arterial digital subtraction angiography of the carotid arteries. Special reference to contrast media.
    Nakstad P; Bakke SJ; Kjartansson O; Nyhus S
    Neuroradiology; 1986; 28(3):195-8. PubMed ID: 3523283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability and efficacy of Hexabrix in cerebral angiography.
    Norman D; Brant-Zawadzki M; Sobel D
    Invest Radiol; 1984; 19(6 Suppl):S306-7. PubMed ID: 6392158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iohexol and iopromide--two new non-ionic water-soluble radiographic contrast media: randomized, intraindividual double-blind study versus ioxaglate in peripheral angiography.
    Hagen B
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():107-14. PubMed ID: 6139064
    [No Abstract]   [Full Text] [Related]  

  • 17. Magnification angiography in moyamoya disease: new observations on collateral vessels.
    Takahashi M
    Radiology; 1980 Aug; 136(2):379-86. PubMed ID: 7403514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The advantage of coronal scanning in cerebral computed angiotomography for diagnosis of moyamoya disease.
    Asari S; Satoh T; Sakurai M; Yamamoto Y; Sadamoto K
    Radiology; 1982 Dec; 145(3):709-11. PubMed ID: 7146400
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of the effect of sodium/meglumine ioxaglate (Hexabrix) on thyroid function.
    Grainger RG; Pennington GW
    Br J Radiol; 1981 Sep; 54(645):768-72. PubMed ID: 7296204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arteriography with ioxaglate (Hexabrix), a new low-osmolar contrast medium. A comparative study on amidotrizoate (Urografin-meglumine) with regard to subjective discomforts].
    Jensen KK; Freiberg H
    Ugeskr Laeger; 1981 Mar; 143(11):673-4. PubMed ID: 7281276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.